89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $46,577,402 | +119.9% | 3,658,869 | 0.0% | 0.89% | +126.7% |
Q3 2022 | $21,185,000 | +79.8% | 3,658,869 | 0.0% | 0.39% | +84.5% |
Q2 2022 | $11,782,000 | -14.6% | 3,658,869 | 0.0% | 0.21% | -4.9% |
Q1 2022 | $13,794,000 | -71.7% | 3,658,869 | -1.9% | 0.22% | -64.3% |
Q4 2021 | $48,744,000 | -33.3% | 3,729,442 | 0.0% | 0.63% | -21.9% |
Q3 2021 | $73,060,000 | +4.8% | 3,729,442 | 0.0% | 0.80% | +13.9% |
Q2 2021 | $69,741,000 | -21.0% | 3,729,442 | 0.0% | 0.70% | -14.6% |
Q1 2021 | $88,313,000 | -2.8% | 3,729,442 | 0.0% | 0.83% | +3.9% |
Q4 2020 | $90,887,000 | -5.0% | 3,729,442 | 0.0% | 0.80% | -33.9% |
Q3 2020 | $95,697,000 | +19.9% | 3,729,442 | -6.9% | 1.20% | +7.0% |
Q2 2020 | $79,809,000 | -21.1% | 4,004,442 | 0.0% | 1.12% | -33.8% |
Q1 2020 | $101,112,000 | -4.0% | 4,004,442 | 0.0% | 1.70% | +13.0% |
Q4 2019 | $105,277,000 | – | 4,004,442 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 393,548 | $9,319,000 | 3.36% |
RA Capital Management | 4,736,214 | $112,154,000 | 1.69% |
Orbimed Advisors | 3,729,442 | $88,313,000 | 0.83% |
Pekin Hardy Strauss, Inc. | 183,275 | $4,340,000 | 0.68% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,007 | $1,184,000 | 0.65% |
DAFNA Capital Management LLC | 105,478 | $2,498,000 | 0.59% |
Parkman Healthcare Partners LLC | 102,163 | $2,419,000 | 0.56% |
Eventide Asset Management | 1,268,539 | $30,039,000 | 0.44% |
Penn Mutual Asset Management, LLC | 16,190 | $383,000 | 0.43% |
Virtus ETF Advisers LLC | 11,351 | $269,000 | 0.11% |